skip to main content
Main Site Navigation
Top of main content
Redefining HealthcareAround You.
Filming this video took place prior to COVID-19 pandemic
WATCH VIDEO
AUDIO DESCRIPTIONS

Treated Conditions

AVM (Arteriovenous Malformation)
Blurry Vision
Carotid and Vertebral Artery Dissection

Research and Clinical Trials

Neuroscience research at Carle represents the intersection of technology, medicine, science, and care. By providing our patients with the opportunity to participate in translational and clinical studies we hope to engage them in not only their own care but also the future of medicine. Our researchers and providers strive to advance diagnostic capabilities, understand causes and effects, and improve patient quality of life. Our research department supports clinicians and faculty alike in their efforts to provide excellent care and perform extraordinary science.

By participating in research studies, Carle Neuroscience Institute seeks to create a better understanding of the structure and function of neurological systems allowing us to advance clinical care possible and ultimately improve the overall promotion of human health and quality of life.

Carle Neuroscience Institute Research is known for demonstrating improved clinical outcomes for patients through research efforts that focus on the development of predictive analysis, novel diagnostics, and comparative efficacy.

Prospective observational study: Identification of brain micrometastatic disease using ultra-high field magnetic resonance imaging

The purpose of this research study is to see if 7Telsa MRI can help health care providers better visualize micrometastatic (really small) tumors in your brain. This study also seeks to better understand how patients’ coping strategies can impact their experience with cancer, acceptance of their diagnosis, and their quality of life. You will be asked to do the following for research purposes: have a 7Telsa MRI and complete quality of life questionnaires once a month for 4 months. The study will continue to follow your health for up to 1 year via review of your medical records.

RAndomized Therapy In Status Epilepticus (RAISE)

This study will evaluate the effectiveness and safety of an investigational product, IV ganaxolone, to treat subjects with status epilepticus.

Ultra-high field imaging of glypmphatic function following traumatic brain injury

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. In the US alone, there are 2.8 million emergency department visits, hospitalizations, and deaths each year, and more than 5.3 million Americans are currently living with a TBI-related disability. Approximately 90% of these injuries are considered ‘mild’ TBI, or concussion. Research is needed to better understand the impacts of traumatic brain injury and ultimately develop new treatments. This research study seeks volunteers with no history of brain injury to serve as comparisons to those with TBI. Using non-invasive, ultra-high field (7 Tesla) MRI technology will allow researchers to see features of the brain that will help improve traumatic brain injury treatment.

SEE MORE CLINICAL TRIALS

Meet Our Team

With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.

MEET OUR TEAM

Online Appointment Scheduling

Online scheduling is now available. Find the provider and time that’s right for you.

Giving

Charitable gifts are used for numerous projects and programs that enhance the healthcare experience for Carle patients and their loved ones. With your support, we’ll advance the care of neurological diseases and meet the needs of the 
ever-expanding Carle Neuroscience Institute.

DONATE NOW LEARN MORE

Related Events

Awards and Accreditations

Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.

  • GL Accredited Hospital
  • Get with the guidelines - 2018 gold plus certified